欧洲疾控中心-欧盟-欧洲经济区的抗菌药物消费（ESAC-Net）-2023年年度流行病学报告（英）
SURVEILLANCE REPORT Antimicrobial consumption in the EU/EEA Annual Epidemiological Report for 2023
报告摘要
SURVEILLANCE REPORT Antimicrobial consumption in the EU/EEA Annual Epidemiological Report for 2023
报告信息
- 文件全名
- 《欧洲疾控中心-欧盟-欧洲经济区的抗菌药物消费（ESAC-Net）-2023年年度流行病学报告（英）-25页.pdf》
- 适合读者
- 核心数据
- 9.6−28.5). This was 1% higher than in 2019 (baseline year), and 4.1 DDD per 1 000 inhabitants per day
- 61.5% in 2023 (country range 41.7%−75.1%). This was 0.4 percentage points higher than 2019 (baseline year)
- and 3.5 percentage points below the 2030 target of > 65%. For the EU overall, there was no statistically
- At EU/EEA level, the most consumed subgroup of antibiotics was penicillins (J01C) (47%), followed by
- macrolides, lincosamides and streptogramins (J01F) (17%), cephalosporins and other beta-lactams (J01D)
- 核心议题
常见问题
《欧洲疾控中心-欧盟-欧洲经济区的抗菌药物消费（ESAC-Net）-2023年年度流行病学报告（英）》主要包含哪些内容?
SURVEILLANCE REPORT Antimicrobial consumption in the EU/EEA Annual Epidemiological Report for 2023核心数据:9.6−28.5). This was 1% higher than in 2019 (baseline year), and 4.1 DDD per 1 000 inhabitants per day;61.5% in 2023 (country range 41.7%−75.1%). This was 0.4 percentage points higher than 2019 (baseline year);and 3.5 percentage points below the 2030 target of > 65%. For the EU overall, there was no statistically。
这份报告由哪家机构发布?
本报告由欧盟发布,发布于 2024 年。
这份报告覆盖哪一年、篇幅多大?
覆盖 2024 年,全文共 25 页。
这份报告是免费的吗?如何获取?
本报告免费查阅,登录资料宝后即可在线获取完整内容。
这份报告适合哪些读者?
适合投资人、行业研究员等读者参考。
报告涉及哪些关键议题?
重点分析了经济等议题。
继续阅读
查看全部 →